1.88
price down icon2.03%   -0.039
 
loading
Schlusskurs vom Vortag:
$1.919
Offen:
$1.9202
24-Stunden-Volumen:
2,127
Relative Volume:
0.12
Marktkapitalisierung:
$173.31M
Einnahmen:
$47.04M
Nettoeinkommen (Verlust:
$-63.98M
KGV:
-2.3313
EPS:
-0.8064
Netto-Cashflow:
$-34.39M
1W Leistung:
+6.21%
1M Leistung:
+4.44%
6M Leistung:
+6.21%
1J Leistung:
-12.96%
1-Tages-Spanne:
Value
$1.87
$1.9202
1-Wochen-Bereich:
Value
$1.7363
$1.98
52-Wochen-Spanne:
Value
$1.29
$3.5107

Innate Pharma Adr Stock (IPHA) Company Profile

Name
Firmenname
Innate Pharma Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
181
Name
Twitter
@InnatePharma
Name
Nächster Verdiensttermin
2024-09-12
Name
Neueste SEC-Einreichungen
Name
IPHA's Discussions on Twitter

Vergleichen Sie IPHA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IPHA
Innate Pharma Adr
1.88 163.13M 47.04M -63.98M -34.39M -0.8064
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Innate Pharma Adr Stock (IPHA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-09-03 Hochstufung SVB Leerink Mkt Perform → Outperform
2020-12-15 Herabstufung SVB Leerink Outperform → Mkt Perform
2020-11-24 Eingeleitet Goldman Neutral

Innate Pharma Adr Aktie (IPHA) Neueste Nachrichten

pulisher
Jul 21, 2025

Cutaneous T-cell Lymphoma Market Anticipates Impressive Growth Trajectory at a CAGR of 7.1% During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 17, 2025

Innate Pharma (NASDAQ:IPHA) Trading 1.7% Higher – What’s Next? - Defense World

Jul 17, 2025
pulisher
Jun 25, 2025

Exchange Traded Concepts LLC Has $112,000 Stock Position in Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) - Defense World

Jun 25, 2025
pulisher
May 28, 2025

Why Kingsoft Cloud Holdings Stock Plummeted by Nearly 8% Today - The Globe and Mail

May 28, 2025
pulisher
May 13, 2025

Earnings call transcript: Innate Pharma Q1 2025 earnings reveal strategic focus By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Innate Pharma Q1 2025 earnings reveal strategic focus - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Innate Pharma Q1 2025 slides: pipeline advances and Sanofi partnership strengthen outlook - Investing.com

May 13, 2025
pulisher
May 13, 2025

Innate Pharma Q1 2025 slides: pipeline advances and Sanofi partnership strengthen outlook By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
Apr 30, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 29, 2025

Innate Pharma stock surges on promising preclinical data By Investing.com - Investing.com South Africa

Apr 29, 2025
pulisher
Apr 29, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 - Investing.com

Apr 29, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock By Investing.com - Investing.com South Africa

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock - Investing.com

Apr 24, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Innate Pharma Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances - Investing.com

Mar 27, 2025
pulisher
Jan 17, 2025

Innate Pharma shares retain Buy rating on long-term strategy - Investing.com

Jan 17, 2025
pulisher
Dec 23, 2024

AZN Stock Price and Chart — LSE:AZN - TradingView

Dec 23, 2024
pulisher
Aug 06, 2024

Contrast Security Introduces Application Detection and Response (ADR) to Identify and Block Attacks and Zero Days on Applications in Production - Business Wire

Aug 06, 2024
pulisher
Jun 10, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

Jun 10, 2024
pulisher
Mar 31, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 31, 2024
pulisher
Jan 04, 2024

Innate Pharma (IPHA) Gains as FDA Lifts Hold on Lymphoma Study - Nasdaq

Jan 04, 2024
pulisher
Apr 29, 2022

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins - Equities.com

Apr 29, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Nov 01, 2019

Innate Pharma (IPHA) Stock Price, News & Analysis - MarketBeat

Nov 01, 2019

Finanzdaten der Innate Pharma Adr-Aktie (IPHA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):